Integrant

Integrant

Enterprise software engineering with AI agents

Overview

Integrant builds enterprise software for regulated industries like medical devices, life sciences, pharma, financial services, manufacturing, and the public sector. Their offerings include full platform development, modernization of legacy systems, or embedding AI agents into client workflows. It uses the Agentic Software Development Life Cycle (ADLC), where AI agents assist across requirements, architecture, build, test, and deployment, while engineers with deep domain knowledge govern every step to ensure quality. Unlike many firms, Integrant combines top-tier engineering talent (the top 1% in a demanding market), a long-track record in regulated environments, and responsible AI acceleration with engineer accountability. Their goal is to be the trusted technology partner clients rely on for mission-critical software that lasts. Headquartered in San Diego with engineering centers in Cairo and Amman.

About Integrant

Simplify's Rating
Why Integrant is rated
D+
Rated D+ on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Industrial & Manufacturing

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

San Diego, California

Founded

1992

Get referred to Integrant

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Integrant closed its Series A on April 25, 2026, signaling investor conviction.
  • Nasdaq granted ticker INGT on April 16, 2026, advancing the November IPO plan.
  • The July 2026 BioWorld profile increased visibility for its cartilage-repair platform.

What critics are saying

  • Integrant still lacks public clinical trial data for its cartilage platform.
  • A November 2026 Nasdaq listing forces execution before regulatory and manufacturing proof.
  • Zimmer Biomet, Stryker, and Smith+Nephew can outspend Integrant across orthopedics, making failure existential.

What makes Integrant unique

  • Integrant combines AI, biologics, and medical devices for cartilage regeneration.
  • Its proprietary CTC Formula became public in Chaos to Creation on May 4, 2026.
  • BioWorld highlighted its meniscus-cartilage platform as a nonreplacement osteoarthritis approach on July 9, 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Social Insurance

Training Programs

Employee Referral Bonus

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Integrant right now.

Find jobs on Simplify and start your career today

We update Integrant's jobs every few hours, so check again soon! Browse all jobs →